Calpain in Breast Cancer: Role in Disease Progression and Treatment Response

Related Experiment Video

Updated: Apr 4, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Sarah J Storr1, Nicola Thompson, Xuan Pu

  • 1Academic Clinical Oncology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham University Hospitals NHS Trust, Nottingham City Hospital Campus, Nottingham, UK.

Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|September 3, 2015
PubMed

Insights

The calpain system, including micro (µ)-calpain and milli (m)-calpain, impacts breast cancer prognosis and treatment response. Calpastatin regulates calpain activity, influencing disease progression and therapeutic outcomes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Calpains are calcium-dependent cysteine proteases involved in cellular processes.
  • Micro (µ)-calpain and milli (m)-calpain are key calpain family members.
  • Calpastatin is the endogenous inhibitor of calpains.

Purpose of the Study:

  • To review the role of the calpain system in breast cancer prognosis.
  • To examine the calpain system's involvement in breast cancer progression.
  • To analyze the impact of the calpain system on responses to breast cancer therapies.

Main Methods:

  • Literature review of studies on calpains in breast cancer.
  • Analysis of calpain expression and function in breast cancer.
  • Evaluation of calpain's role in treatment response.

Main Results:

  • Calpain system activity correlates with breast cancer prognosis and progression.
  • Calpain system influences efficacy of chemotherapy, endocrine therapy, and targeted therapies.
  • Calpastatin levels may modulate treatment outcomes.

Conclusions:

  • The calpain system is a significant factor in breast cancer development and progression.
  • Targeting the calpain system could offer novel therapeutic strategies for breast cancer.
  • Understanding calpain-calpastatin interactions is crucial for optimizing breast cancer treatment.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.7K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Tumor Progression02:07

Tumor Progression

3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K